“…Hydantoin analogues have been identified as anticancer [8,9], anticonvulsants [10], anti-inflammatory [11,12], anti-HIV [13], antidiabetics [14], antimuscarinics [15,16], antiulcers and antiarrythmics [17,18], antihypertensive [19], serotonin and fibrinogen receptor antagonists [20,21], inhibitors of the glycine binding site of the NMDA receptor [22] and antagonists of leukocyte cell adhesion acting as allosteric inhibitors of the protein-protein interaction [23]. As part of our ongoing studies concerning the preparation of potential biologically active compounds [24][25][26][27], we were interested in the synthesis of diversely substituted diazaspiro hydantoin derivatives.…”